This week's FierceBiotech is brought to you by Baxter. We will be attending or exhibiting at the following upcoming industry events:ICSE USA and PHARMAPACK North AmericaMay 22 - 23,
2012Philadelphia, PAPennsylvania Convention CenterBooth 507ASCO Annual MeetingJune 1 - 5, 2012Chicago, IllinoisMcCormick PlaceBIO InternationalJune 18 - 21, 2012Boston, MABoston Convention &
Exhibition CenterSafeBridge recognizes Baxter facilities in GermanyBaxter facilities in Halle and Bielefeld, located in Germany's Westfalen region, have been recognized and certified for their
capabilities in handling potent pharmaceutical compounds by SafeBridge Consultants, Inc., a leading occupational health and safety consulting firm. Baxter is the only company worldwide with facilities
certified by SafeBridge doing both parenteral drug substance synthesis and parenteral drug product manufacturing and testing.The facilities in Halle and Bielefeld support Baxter's BioPharma Solutions
business, a contract manufacturing organization that partners with pharmaceutical companies to support their commercialization objectives.Dr Burkhard Wichert, Vice Presidentof Manufacturing,
Oncology"Baxter is honored to be recognized by SafeBridge for our safe handling of potent pharmaceutical compounds and demonstrating our abilities to handle and manufacture these materials to industry
standards," said Dr Burkhard Wichert, Vice President of Manufacturing, Oncology, for Baxter's Halle facility. "We take seriously our commitment to our pharmaceutical partners and, ultimately, the
patients who rely on the critical medications manufactured at our facilities in Halle and Bielefeld."SafeBridge Certification provides an objective and scientific assessment of a company's ability to
safely handle and manufacture to industry standards potent compounds such as oncology drugs, steroid and peptide hormones, and new generations of opioids. It demonstrates that Baxter manufactures
these compounds not only according to U.S. Food and Drug Administration, European, and German laws, but in line with international industry occupational health standards as well. In addition to the
recent SafeBridge Certification, the Halle facility is OHSAS 18001 and ISO14001 certified.Halle facility capabilities include:LyophilizationProcess developmentAseptic filling of oncology products and
highly potent liquid and sterile powder vials in clinical and commercial batch sizesAntibody-drug conjugatesLiposomesSterile crystallization of potent active pharmaceutical ingredientsTo read more,
please visit http://link.replaced.localFor more information on the services and solutions we offer, visit baxterbiopharmasolutions.com2010/2011/2012 - Vaccine Industry Excellence Awards, Best Contract
Manufacturing Organization2009 Winner of European Outsourcing AwardWantto reach 100,000+ FierceBiotech subscribers with your own message?Contact xyz@noemail.localor call 202-824-5041. About this
email: Inorder to receive FierceBiotech for free, we ask that you accept anoccasional email promotion from our sponsors. We carefully screeneach promotion and never sell or give away your personal
information. Ifyou do not want to receive these messages, you can unsubscribe entirelyfrom FierceBiotech.Click here to unsubscribe.FierceMarkets1900 L St. NW Suite 400 Washington, DC 20036
